共 16 条
[1]
Gommolon F(2014)Biosimilars: are they bioequivalent Dig Dis 32 82-7
[2]
Braido F(2012)From “blockbusters” to “biosimilars”: an opportunity for patients, medical specialists and health care providers Pulm Pharmacol Ther 25 483-6
[3]
Holgate S(2014)Regulatory and clinical considerations for biosimilar oncology drugs Lancet Oncol 15 e594-605
[4]
Canonica GW(2014)Systematic verification of bioanalytical similarity between a biosimilar and a reference biotherapeutic: committee recommendations for the development and validation of a single ligandbinding assay to support pharmacokinetic assessments AAPS J 16 1149-58
[5]
Bennett CL(undefined)undefined undefined undefined undefined-undefined
[6]
Chen B(undefined)undefined undefined undefined undefined-undefined
[7]
Hermanson T(undefined)undefined undefined undefined undefined-undefined
[8]
Wyatt MD(undefined)undefined undefined undefined undefined-undefined
[9]
Schulz RM(undefined)undefined undefined undefined undefined-undefined
[10]
Georgantopoulos P(undefined)undefined undefined undefined undefined-undefined